메뉴 건너뛰기




Volumn 8, Issue 2, 2016, Pages 1295-1301

Ranolazine attenuated heightened plasma norepinephrine and B-type natriuretic peptide-45 in improving cardiac function in rats with chronic ischemic heart failure

Author keywords

Brain natriuretic peptide; Myocardial infarction; Norepinephrine; Ranolazine

Indexed keywords

B TYPE NATRIURETIC PEPTIDE 45; BRAIN NATRIURETIC PEPTIDE; NORADRENALIN; RANOLAZINE; UNCLASSIFIED DRUG;

EID: 84962044497     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (8)

References (31)
  • 1
    • 33745392178 scopus 로고    scopus 로고
    • Late sodium current in the pathophysiology of cardiovascular disease: Consequences of sodium-calcium overload
    • Noble D, Noble PJ. Late sodium current in the pathophysiology of cardiovascular disease: consequences of sodium-calcium overload. Heart 2006; 92: 41-45.
    • (2006) Heart , vol.92 , pp. 41-45
    • Noble, D.1    Noble, P.J.2
  • 2
    • 84891675409 scopus 로고    scopus 로고
    • Efficacy and safety of ranolazine in patients with chronic stable angina
    • Kloner RA, Hines ME, Geunes-Boyer S. Efficacy and safety of ranolazine in patients with chronic stable angina. Postgrad Med 2014; 125: 43-52.
    • (2014) Postgrad Med , vol.125 , pp. 43-52
    • Kloner, R.A.1    Hines, M.E.2    Geunes-Boyer, S.3
  • 3
    • 70449090162 scopus 로고    scopus 로고
    • Ranolazine, an antianginal agent, markedly reduces ventricular arrhythmias induced by ischemia and ischemia-reperfusion
    • Dhalla AK, Wang WQ, Dow J, Shryock JC, Belardinelli L, Bhandari A. Ranolazine, an antianginal agent, markedly reduces ventricular arrhythmias induced by ischemia and ischemia-reperfusion. Am J Physiol Heart Circ Physiol 2009; 297: H1923-1929.
    • (2009) Am J Physiol Heart Circ Physiol , vol.297 , pp. H1923-H1929
    • Dhalla, A.K.1    Wang, W.Q.2    Dow, J.3    Shryock, J.C.4    Belardinelli, L.5    Bhandari, A.6
  • 4
    • 84895195235 scopus 로고    scopus 로고
    • The usefulness of ranolazine for the treatment of refractory chronic stable angina pectoris as determined from a systematic review of randomized controlled trials
    • Banon D, Filion KB, Budlovsky T, Franck C, Eisenberg MJ. The usefulness of ranolazine for the treatment of refractory chronic stable angina pectoris as determined from a systematic review of randomized controlled trials. Am J Cardiol 2014; 113: 1075-1082.
    • (2014) Am J Cardiol , vol.113 , pp. 1075-1082
    • Banon, D.1    Filion, K.B.2    Budlovsky, T.3    Franck, C.4    Eisenberg, M.J.5
  • 5
    • 84930716398 scopus 로고    scopus 로고
    • Ranolazine treatment for myocardial infarction? Effects on the development of necrosis, left ventricular function and arrhythmias in experimental models
    • Hale SL, Kloner RA. Ranolazine treatment for myocardial infarction? Effects on the development of necrosis, left ventricular function and arrhythmias in experimental models. Cardiovasc Drugs Ther 2014; 28: 469-475.
    • (2014) Cardiovasc Drugs Ther , vol.28 , pp. 469-475
    • Hale, S.L.1    Kloner, R.A.2
  • 7
    • 84944321678 scopus 로고    scopus 로고
    • Eplerenone attenuates cardiac dysfunction and oxidative stress in betareceptor stimulated myocardial infarcted rats
    • Reddy NM, Mahajan UB, Patil CR, Agrawal YO, Ojha S, Goyal SN. Eplerenone attenuates cardiac dysfunction and oxidative stress in betareceptor stimulated myocardial infarcted rats. Am J Transl Res 2015; 7: 1602-1611.
    • (2015) Am J Transl Res , vol.7 , pp. 1602-1611
    • Reddy, N.M.1    Mahajan, U.B.2    Patil, C.R.3    Agrawal, Y.O.4    Ojha, S.5    Goyal, S.N.6
  • 10
    • 17444440057 scopus 로고
    • Autonomic response to coronary occlusion in animals susceptible to ventricular fibrillation
    • Collins MN, Billman GE. Autonomic response to coronary occlusion in animals susceptible to ventricular fibrillation. Am J Physiol 1989; 257: H1886-1894.
    • (1989) Am J Physiol , vol.257 , pp. H1886-H1894
    • Collins, M.N.1    Billman, G.E.2
  • 11
    • 0025653393 scopus 로고
    • Sympathetic--parasympathetic interaction and sudden death
    • Vanoli E, Schwartz PJ. Sympathetic--parasympathetic interaction and sudden death. Basic Res Cardiol 1990; 85: 305-321.
    • (1990) Basic Res Cardiol , vol.85 , pp. 305-321
    • Vanoli, E.1    Schwartz, P.J.2
  • 12
    • 31944447449 scopus 로고    scopus 로고
    • Sympathetic nervous system neuroplasticity
    • Esler M, Kaye D. Sympathetic nervous system neuroplasticity. Hypertension 2006; 47: 143-144.
    • (2006) Hypertension , vol.47 , pp. 143-144
    • Esler, M.1    Kaye, D.2
  • 14
    • 33847066216 scopus 로고    scopus 로고
    • Plasma brain natriuretic peptide correlates with infarct size but not with subsequent remodeling in the rat heart
    • Maczewski M, Mackiewicz U. Plasma brain natriuretic peptide correlates with infarct size but not with subsequent remodeling in the rat heart. Cardiovasc Pathol 2007; 16: 79-84.
    • (2007) Cardiovasc Pathol , vol.16 , pp. 79-84
    • Maczewski, M.1    Mackiewicz, U.2
  • 15
    • 33750513635 scopus 로고    scopus 로고
    • Brain natriuretic peptide and other risk markers for outcome assess ment in patients with non-ST-elevation coronary syndromes and preserved systolic function
    • Palazzuoli A, Deckers J, Calabro A, Campagna MS, Nuti R, Pastorelli M, Pasgui AL, Bruni F, Auteri A, Puccetti L. Brain natriuretic peptide and other risk markers for outcome assess ment in patients with non-ST-elevation coronary syndromes and preserved systolic function. Am J Cardiol 2006; 98: 1322-1328.
    • (2006) Am J Cardiol , vol.98 , pp. 1322-1328
    • Palazzuoli, A.1    Deckers, J.2    Calabro, A.3    Campagna, M.S.4    Nuti, R.5    Pastorelli, M.6    Pasgui, A.L.7    Bruni, F.8    Auteri, A.9    Puccetti, L.10
  • 16
    • 0037432301 scopus 로고    scopus 로고
    • Val-HeFT Investigators. Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT)
    • Anand IS, Fisher LD, Chiang YT, Latini R, Masson S, Maggioni AP, Glazer RD, Tognoni G, Cohn JN; Val-HeFT Investigators. Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 2003; 107: 1278-1283.
    • (2003) Circulation , vol.107 , pp. 1278-1283
    • Anand, I.S.1    Fisher, L.D.2    Chiang, Y.T.3    Latini, R.4    Masson, S.5    Maggioni, A.P.6    Glazer, R.D.7    Tognoni, G.8    Cohn, J.N.9
  • 17
    • 73449094578 scopus 로고    scopus 로고
    • Prognostic Value of Emerging Neurohormones in Chronic Heart Failure during Optimization of Heart Failure-Specific Therapy
    • Neuhold S, Huelsmann M, Strunk G, Struck J, Adlbrecht C, Gouya G. Prognostic Value of Emerging Neurohormones in Chronic Heart Failure during Optimization of Heart Failure-Specific Therapy. Clin Chem 2010; 56: 121-126.
    • (2010) Clin Chem , vol.56 , pp. 121-126
    • Neuhold, S.1    Huelsmann, M.2    Strunk, G.3    Struck, J.4    Adlbrecht, C.5    Gouya, G.6
  • 18
    • 33646140572 scopus 로고    scopus 로고
    • Clinical Pharmacokinetics of Ranolazine
    • Jerling M. Clinical Pharmacokinetics of Ranolazine. Clin Pharmacokinet 2006; 45: 469-491.
    • (2006) Clin Pharmacokinet , vol.45 , pp. 469-491
    • Jerling, M.1
  • 19
    • 18344393246 scopus 로고    scopus 로고
    • Posttranscriptional Control of BNP Gene Expression in Angiotensin II-Induced Hypertension
    • Suo M, Hautala N, Földes G, Szokodi I, Tóth M, Leskinen H. Posttranscriptional Control of BNP Gene Expression in Angiotensin II-Induced Hypertension. Hypertension 2002; 39: 803-808.
    • (2002) Hypertension , vol.39 , pp. 803-808
    • Suo, M.1    Hautala, N.2    Földes, G.3    Szokodi, I.4    Tóth, M.5    Leskinen, H.6
  • 20
    • 0022591615 scopus 로고
    • Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure
    • Leimbach WN, Wallin BG, Victor RG, Aylward PE, Sundlöf G, Mark AL. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation 1986; 73: 913-919.
    • (1986) Circulation , vol.73 , pp. 913-919
    • Leimbach, W.N.1    Wallin, B.G.2    Victor, R.G.3    Aylward, P.E.4    Sundlöf, G.5    Mark, A.L.6
  • 22
    • 0025287313 scopus 로고
    • Sympathetic activity and regional blood flow in heart failure
    • Dargie H. Sympathetic activity and regional blood flow in heart failure. Eur Heart J 1990; 11: 39-43.
    • (1990) Eur Heart J , vol.11 , pp. 39-43
    • Dargie, H.1
  • 24
    • 0027524995 scopus 로고
    • Factors contributing to the exercise limitation of heart failure
    • Wilson JR, Mancini DM. Factors contributing to the exercise limitation of heart failure. J Am Coll Cardiol 1993; 22: 93A-8A.
    • (1993) J am Coll Cardiol , vol.22 , pp. 8A-93A
    • Wilson, J.R.1    Mancini, D.M.2
  • 25
    • 0037382775 scopus 로고    scopus 로고
    • Partial fatty acid oxidation (PFOX) inhibition: A new therapy for chronic stable angina
    • Conti CR. Partial fatty acid oxidation (pFOX) inhibition: a new therapy for chronic stable angina. Clin Cardiol 2003; 26: 161-162.
    • (2003) Clin Cardiol , vol.26 , pp. 161-162
    • Conti, C.R.1
  • 26
    • 0035917675 scopus 로고    scopus 로고
    • Ranolazine, a partial fatty acid oxidation inhibitor, reduces myocardial infarct size and cardiac troponin T release in the rat
    • Zacharowski K, Blackburn B, Thiemermann C. Ranolazine, a partial fatty acid oxidation inhibitor, reduces myocardial infarct size and cardiac troponin T release in the rat. Eur J Pharmacol 2001; 418: 105-110.
    • (2001) Eur J Pharmacol , vol.418 , pp. 105-110
    • Zacharowski, K.1    Blackburn, B.2    Thiemermann, C.3
  • 27
    • 33947431938 scopus 로고    scopus 로고
    • A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion
    • Wang P, Fraser H, Lloyd SG, McVeigh JJ, Belardinelli L, Chatham JC. A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion. J Pharmacol Exp Ther 2007; 321: 213-220.
    • (2007) J Pharmacol Exp Ther , vol.321 , pp. 213-220
    • Wang, P.1    Fraser, H.2    Lloyd, S.G.3    McVeigh, J.J.4    Belardinelli, L.5    Chatham, J.C.6
  • 28
    • 0348129532 scopus 로고    scopus 로고
    • Combination Assessment of Ranolazine in Stable Angina (CARISA) Investigator. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: A randomized controlled trial
    • Chaitman BR, Pepine CJ, Parker JO, Skopal J, Chumakova G, Kuch J, Wang W, Skettino SL, Wolff AA. Combination Assessment of Ranolazine in Stable Angina (CARISA) Investigator. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. JAMA 2007; 291: 309-316.
    • (2007) JAMA , vol.291 , pp. 309-316
    • Chaitman, B.R.1    Pepine, C.J.2    Parker, J.O.3    Skopal, J.4    Chumakova, G.5    Kuch, J.6    Wang, W.7    Skettino, S.L.8    Wolff, A.A.9
  • 29
    • 0035080560 scopus 로고    scopus 로고
    • Evidence that ranolazine behaves as a weak beta1-and beta2-adrenoceptor antagonist in the rat [correction of cat] cardiovascular system
    • Letienne R, Vie B, Puech A, Vieu S, Le Grand B, John GW. Evidence that ranolazine behaves as a weak beta1-and beta2-adrenoceptor antagonist in the rat [correction of cat] cardiovascular system. Naunyn Schmiedebergs Arch Pharmacol 2001; 363: 464-471.
    • (2001) Naunyn Schmiedebergs Arch Pharmacol , vol.363 , pp. 464-471
    • Letienne, R.1    Vie, B.2    Puech, A.3    Vieu, S.4    Le Grand, B.5    John, G.W.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.